What is Mounjaro?

An introduction to Mounjaro, the brand name for tirzepatide approved for type 2 diabetes.

Last updated: January 28, 2026

What is Mounjaro?

Mounjaro is the brand name for tirzepatide, a medication FDA-approved for treating type 2 diabetes. It’s manufactured by Eli Lilly and was approved in May 2022. Mounjaro is notable for being the first dual GIP/GLP-1 receptor agonist.

How is Mounjaro Different from Zepbound?

Both contain tirzepatide but are approved for different conditions:

FeatureMounjaroZepbound
Approved ForType 2 diabetesWeight management
ManufacturerEli LillyEli Lilly
FDA ApprovalMay 2022November 2023
Doses Available2.5-15 mg2.5-15 mg

How Does Mounjaro Work?

Mounjaro is unique because it activates two hormone receptors instead of one:

GLP-1 Receptor Activation

GIP Receptor Activation

  • Enhances insulin secretion
  • May improve fat metabolism
  • Complements GLP-1 effects

This dual action is why tirzepatide is called a “twincretin.”

What is Mounjaro Approved For?

FDA-Approved Indication

Can Be Used

  • As monotherapy (alone)
  • With other diabetes medications
  • With or without metformin

Not Approved For

  • Weight management (use Zepbound)
  • Type 1 diabetes
  • Diabetic ketoacidosis

What Does the Research Show?

The SURPASS clinical trial program demonstrated strong results:

TrialComparisonHbA1c Reduction (15 mg)
SURPASS-1vs placebo-2.07%
SURPASS-2vs semaglutide 1 mg-2.30% vs -1.86%
SURPASS-3vs insulin degludec-2.37% vs -1.34%

Many participants achieved HbA1c levels below 5.7% (non-diabetic range).

Key Facts

FactDetail
AdministrationOnce weekly injection
Starting Dose2.5 mg (titrated up)
Maximum Dose15 mg
DevicePre-filled single-dose pen

Common Side Effects

  • Nausea (usually mild and temporary)
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation

Who Should Not Use Mounjaro?

  • People with personal or family history of medullary thyroid carcinoma
  • People with Multiple Endocrine Neoplasia syndrome type 2
  • Those with known hypersensitivity to tirzepatide

This guide is for educational purposes only. Mounjaro is a prescription medication requiring medical supervision.

Related Content

Get Research Alerts

New dossiers and major study summaries delivered to your inbox. No spam, just evidence.

No spam. Unsubscribe anytime.

Disclaimer: This educational guide does not constitute medical advice. The information presented is based on current research but should not be used for diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before making health decisions.